Increased urinary 15-F<sub>2t</sub>-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress

Abstract

Urinary 15-F2t-isoprostane concentrations increased in proportion to the severity of CHF in patients. This may be caused by increased 15-F2t-isoprostane production. These findings suggest that urinary 15-F2t-isoprostane may be a marker of morbidity as well as oxidative stress in patients with CHF.

References

Page 1

	Year	Citations
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Jason D. Morrow, Kristina E. Hill, Raymond F. Burk, Proceedings of the National Academy of Sciences Lipid PeroxidationSecondary MetaboliteRedox BiologyFree Radical-catalyzed MechanismOxidative Stress	1990	1.9K
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Kalon K.L. Ho, Karen M. Anderson, Kannel Wb, Circulation	1993	1.9K
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda, Circulation	1997	961
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Jason D. Morrow, Joseph Awad, H. J. Boss, Proceedings of the National Academy of Sciences Lipid AnalysisLipid PeroxidationSecondary MetaboliteLipid ExtractsFree F2-isoprostanes	1992	736
Left ventricular volume from paired biplane two-dimensional echocardiography. N B Schiller, Harry Acquatella, Thomas A. Ports, Circulation Consecutive PatientsHeart FailureMedical ImagingCardiovascular DiseaseCardiac Mechanic	1979	609
Interleukin-6 Spillover in the Peripheral Circulation Increases With the Severity of Heart Failure, and the High Plasma Level of Interleukin-6 Is an Important Prognostic Predictor in Patients With Congestive Heart Failure Takayoshi Tsutamoto, Tomoko Hisanaga, Atsuyuki Wada, Journal of the American College of Cardiology InflammationHeart FailureCardiovascular DiseaseVascular BiologyCardiac Care	1998	561
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada. Mary Keith, Amir Geranmayegan, Michael J. Sole, Journal of the American College of Cardiology Heart FailureCardiorenal SyndromesCardiovascular DiseasePhysiologyCardiovascular Pharmacology	1998	555
Elevated Levels of 8-iso-Prostaglandin F<sub>2α</sub>in Pericardial Fluid of Patients With Heart Failure Ziad Mallat, Ivan Philip, Maryline Lebret, Circulation	1998	447
Role of oxidative stress in transition of hypertrophy to heart failure Arvinder K. Dhalla, Michael F. Hill, Pawan K. Singal Journal of the American College of Cardiology Reductive StressCardiomyopathyHeart FailureCardiovascular DiseaseBiochemistry	1996	422
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure Keiko Maeda, Takayoshi Tsutamoto, Atsuyuki Wada, Journal of the American College of Cardiology Independent Risk FactorsHeart FailureCardiovascular DiseaseCardiac CareCongestive Heart Failure	2000	416

Page 1